These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2627615)

  • 21. Neopterin and interferon gamma serum levels in renal allograft recipients.
    Khoss AE; Balzar E; Steger H; Howanietz H; Wladika W; Hamilton G; Woloszczuk W
    Child Nephrol Urol; 1988-1989; 9(1-2):46-9. PubMed ID: 3150820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring the response to anti-rejection therapy with serum neopterin.
    Smillie AE; Rigby RJ; Petrie JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
    Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
    Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of neopterin by a commercial radioimmunoassay in aortocoronary bypass surgery and heart transplantation].
    Vogt S; Hippe K
    Z Med Lab Diagn; 1991; 32(3-4):193-6. PubMed ID: 1897298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neopterin: marker of cellular immunity activation in idiopathic inflammatory myopathy].
    Nasonov EL; Samsonov MI; Shtutman VZ; Gekht BM; Gurkina GT; Tilz GP; Guseva NG; Fuchs D; Wachter H
    Klin Med (Mosk); 1997; 75(2):47-51. PubMed ID: 9157218
    [No Abstract]   [Full Text] [Related]  

  • 26. [The serum neopterin level in acute rheumatic fever].
    Samsonov MIu; Dzhuzenova BS; Nasonov EL; Meshcheriakov VG; Belenkov IuN; Nasonova VA
    Ter Arkh; 1992; 64(5):69-72. PubMed ID: 1455382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
    Bonnotte B; Burdiles AM; Chehimi J; Carayol G; Pardoux C; Dietrich PY; Kubin M; Blay JY; Caignard A; Ibrahim A; Robinet E; Hayat M; Pico JL; Bourhis JH; Chouaib S
    Eur Cytokine Netw; 1996 Sep; 7(3):389-94. PubMed ID: 8954182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
    Przepiorka D; Chan KW; Champlin RE; Culbert SJ; Petropoulos D; Ippoliti C; Khouri I; Huh YO; Vreisendorp H; Deisseroth AB
    Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone marrow grafts from unrelated donors].
    Esperou-Bourdeau H
    Rev Prat; 1994 Sep; 44(14):1851-4. PubMed ID: 7939273
    [No Abstract]   [Full Text] [Related]  

  • 30. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation.
    Hempel L; Körholz D; Nussbaum P; Bönig H; Burdach S; Zintl F
    Bone Marrow Transplant; 1997 Sep; 20(5):365-8. PubMed ID: 9339750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K
    Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
    Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DP matching in allogeneic bone marrow transplantation.
    Pawelec G; Ehninger G; Schmidt H; Rehbein A; Balko I; Wernet P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2741-3. PubMed ID: 3274584
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute graft-versus-host disease following bone marrow transplantation in humans: prognostic factors. Advisory Committee of the International Bone Marrow Transplant Registry.
    Bortin MM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2655-7. PubMed ID: 3274576
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neopterin and creatinine relationships in liver and kidney transplants.
    Takasugi M; Ward HJ; Colonna J; Busuttil RW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2056-8. PubMed ID: 2652673
    [No Abstract]   [Full Text] [Related]  

  • 39. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of longitudinal complement measurements in recipients of bone marrow transplant.
    Varga L; Poros A; Puskás E; Pánya A; Kramer J; Gyódi E; Füst G
    Bone Marrow Transplant; 1995 Apr; 15(4):509-14. PubMed ID: 7655374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.